T1	PROC 44 88	Estudio para evaluar la Eficacia y Seguridad
T2	CHEM 92 99	ABT-493
#1	AnnotatorNotes T2	C4310002; ABT-493; Organic Chemical · Pharmacologic Substance
T3	PROC 113 140	trasplante hepático o renal
T4	ANAT 135 140	renal
#2	AnnotatorNotes T4	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T5	PROC 198 232	Estudio abierto y de un solo grupo
T6	PROC 238 272	evaluar la seguridad y la eficacia
#3	AnnotatorNotes T6	C0511730; Identify product efficacy and safety issues; Health Care Activity
T7	CHEM 284 291	ABT-530
#4	AnnotatorNotes T7	C4310001; ABT-530; Organic Chemical · Pharmacologic Substance
T8	PROC 333 360	trasplante hepático o renal
T9	ANAT 355 360	renal
#5	AnnotatorNotes T9	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T10	DISO 366 414	infección crónica por el virus de la hepatitis C
#6	AnnotatorNotes T10	C0524910; Hepatitis C, Chronic; Disease or Syndrome
T11	DISO 512 529	Virus Hepatitis C
T12	DISO 470 473	VHC
#7	AnnotatorNotes T12	C0019196; Hepatitis C; Disease or Syndrome
T13	DISO 686 703	infección por VHC
T14	ANAT 885 890	riñon
#8	AnnotatorNotes T14	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T15	PROC 746 766	trasplante de hígado
#9	AnnotatorNotes T15	C0023911; Transplantation of liver; Therapeutic or Preventive Procedure
T16	PROC 1689 1699	trasplante
#10	AnnotatorNotes T16	C0040732; Transplantation; Therapeutic or Preventive Procedure
T17	DISO 816 833	infección por VHC
T18	CHEM 1100 1110	tacrolimus
#11	AnnotatorNotes T18	C0085149; tacrolimus; Organic Chemical · Pharmacologic Substance
T19	CHEM 1112 1121	sirolimus
#12	AnnotatorNotes T19	C0072980; sirolimus; Antibiotic · Organic Chemical
T20	CHEM 1123 1133	everolimus
#13	AnnotatorNotes T20	C0541315; everolimus; Organic Chemical · Pharmacologic Substance
T21	CHEM 1135 1155	mofetil micofenolato
#14	AnnotatorNotes T21	C0209368; mycophenolate mofetil; Organic Chemical · Pharmacologic Substance
T22	CHEM 1157 1168	azatioprina
#15	AnnotatorNotes T22	C0004482; azathioprine; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance
T23	CHEM 1172 1184	ciclosporina
#16	AnnotatorNotes T23	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T24	CHEM 1369 1379	medicación
#17	AnnotatorNotes T24	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T25	DISO 1416 1437	hepatitis colestásica
#18	AnnotatorNotes T25	C0149904; Cholestatic hepatitis; Disease or Syndrome
T26	ANAT 1479 1484	riñon
#19	AnnotatorNotes T26	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T27	PROC 1453 1484	Re-trasplante de hígado o riñon
T28	CHEM 1509 1519	esteroides
#20	AnnotatorNotes T28	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T29	ANAT 1524 1530	hígado
#21	AnnotatorNotes T29	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T30	ANAT 1537 1542	riñón
#22	AnnotatorNotes T30	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T31	PROC 1543 1555	trasplantado
#23	AnnotatorNotes T31	C0040732; Transplantation; Therapeutic or Preventive Procedure
T32	DISO 1575 1582	rechazo
T33	CHEM 1596 1606	esteroides
#24	AnnotatorNotes T33	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T34	DISO 1669 1699	complicaciones post-trasplante
T35	PROC 1583 1591	tratados
#25	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	ANAT 1720 1740	vasculatura hepática
T37	DISO 1488 1495	Rechazo
T38	CHEM 100 107	ABT-530
#26	AnnotatorNotes T38	C4310001; ABT-530; Organic Chemical · Pharmacologic Substance
T39	ANAT 124 132	hepático
#27	AnnotatorNotes T39	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T40	DISO 145 176	virus de la hepatitis C crónico
T41	CHEM 276 283	ABT-493
#28	AnnotatorNotes T41	C4310002; ABT-493; Organic Chemical · Pharmacologic Substance
T42	ANAT 344 352	hepático
#29	AnnotatorNotes T42	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T43	DISO 416 419	VHC
#30	AnnotatorNotes T43	C0019196; Hepatitis C; Disease or Syndrome
T44	ANAT 760 766	hígado
#31	AnnotatorNotes T44	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T45	DISO 785 791	muerto
#32	AnnotatorNotes T45	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T46	DISO 909 915	muerto
#33	AnnotatorNotes T46	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T47	DISO 1007 1017	cirróticos
#34	AnnotatorNotes T47	C1623038; Cirrhosis; Disease or Syndrome
T48	PROC 1058 1081	régimen inmunosupresivo
T49	ANAT 1470 1476	hígado
#35	AnnotatorNotes T49	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T50	Date 12 16	2015
T51	LIVB 145 168	virus de la hepatitis C
#36	AnnotatorNotes T51	C0220847; hepatitis C virus; Virus
T52	Duration 169 176	crónico
#37	AnnotatorNotes T52	C0205191; chronic; Temporal Concept
T53	LIVB 295 302	adultos
#38	AnnotatorNotes T53	C0001675; Adult; Age Group
T54	Duration 376 383	crónica
#39	AnnotatorNotes T54	C0205191; chronic; Temporal Concept
T55	LIVB 391 414	virus de la hepatitis C
#40	AnnotatorNotes T55	C0220847; hepatitis C virus; Virus
T57	PROC 421 430	genotipos
#41	AnnotatorNotes T57	C1285573; Genotype determination; Laboratory Procedure
T59	PROC 474 482	Genotipo
#42	AnnotatorNotes T59	C1285573; Genotype determination; Laboratory Procedure
T61	LIVB 558 565	Hombres
#43	AnnotatorNotes T61	C0025266; Male population group; Population Group
T62	LIVB 568 575	mujeres
#44	AnnotatorNotes T62	C0043210; Woman; Population Group
T63	Age 580 596	al menos 18 años
T64	LIVB 700 703	VHC
#45	AnnotatorNotes T64	C0220847; hepatitis C virus; Virus
T65	LIVB 716 724	paciente
#46	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	LIVB 770 791	donante vivo o muerto
#47	AnnotatorNotes T66	C0348050; Living donor; Population Group + C0524354; Cadaver donor; Population Group
T67	LIVB 830 833	VHC
#48	AnnotatorNotes T67	C0220847; hepatitis C virus; Virus
T68	Duration 834 843	> 3 meses
T69	LIVB 865 873	paciente
#49	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T70	LIVB 894 915	donante vivo o muerto
#50	AnnotatorNotes T70	C0348050; Living donor; Population Group + C0524354; Cadaver donor; Population Group
T71	Duration 916 934	al menos > 3 meses
T72	LIVB 966 975	pacientes
#51	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T73	LIVB 1024 1032	paciente
#52	AnnotatorNotes T73	C0030705; Patients; Patient or Disabled Group
T74	Date 1038 1049	actualmente
T75	LIVB 1214 1233	Mujeres embarazadas
#53	AnnotatorNotes T75	C0033011; Pregnant Women; Population Group
T76	PHYS 1235 1246	amamantando
#54	AnnotatorNotes T76	C0006147; Breast Feeding; Organism Function
T77	Duration 1318 1341	aproximadamente 30 dias
T78	CONC 1350 1362	última dosis
T79	Dose 1607 1617	alta dosis
T80	Duration 1628 1639	los 3 meses
T81	Date 1684 1699	post-trasplante
T83	PHYS 1285 1296	embarazadas
#55	AnnotatorNotes T83	C0032961; Pregnancy; Organism Function
T56	LIVB 731 739	receptor
#56	AnnotatorNotes T56	C0376387; Transplant Recipients; Patient or Disabled Group
T58	Neg_cue 1004 1006	no
T60	PHYS 1222 1233	embarazadas
#57	AnnotatorNotes T60	C0032961; Pregnancy; Organism Function
T82	LIVB 316 326	receptores
#58	AnnotatorNotes T82	C0376387; Transplant Recipients; Patient or Disabled Group
A1	Population_data T53 Age
A2	Assertion T47 Negated
A3	Status T25 History_of
A4	Status T32 History_of
A5	Status T34 History_of
A6	Status T16 History_of
#59	AnnotatorNotes T1	C0511730; Identify product efficacy and safety issues; Health Care Activity
#60	AnnotatorNotes T3	C0023911; Transplantation of liver; Therapeutic or Preventive Procedure + C0022671; Kidney Transplantation; Therapeutic or Preventive Procedure
#61	AnnotatorNotes T40	C0524910; Hepatitis C, Chronic; Disease or Syndrome 
#62	AnnotatorNotes T5	C2826346; Single Group Study; Research Activity + C1709323; Open Label Study; Research Activity 
#63	AnnotatorNotes T8	C0023911; Transplantation of liver; Therapeutic or Preventive Procedure + C0022671; Kidney Transplantation; Therapeutic or Preventive Procedure
#64	AnnotatorNotes T11	C0019196; Hepatitis C; Disease or Syndrome
#65	AnnotatorNotes T13	C0019196; Hepatitis C; Disease or Syndrome
#66	AnnotatorNotes T17	C0019196; Hepatitis C; Disease or Syndrome
#67	AnnotatorNotes T74	C0521116; Current (present time); Temporal Concept 
#68	AnnotatorNotes T48	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure 
R1	Combined_with Arg1:T2 Arg2:T38	
R2	Combined_with Arg1:T41 Arg2:T7	
R3	Location_of Arg1:T39 Arg2:T3	
R4	Location_of Arg1:T4 Arg2:T3	
R5	Causes Arg1:T51 Arg2:T40	
R6	Has_Duration_or_Interval Arg1:T40 Arg2:T52	
R7	After Arg1:T2 Arg2:T3	
R8	After Arg1:T38 Arg2:T3	
R9	Experiences Arg1:T53 Arg2:T41	
R10	Experiences Arg1:T82 Arg2:T41	
R11	Experiences Arg1:T53 Arg2:T8	
R12	Experiences Arg1:T82 Arg2:T8	
R13	Location_of Arg1:T42 Arg2:T8	
R14	Location_of Arg1:T9 Arg2:T8	
R15	Experiences Arg1:T53 Arg2:T10	
R16	Experiences Arg1:T82 Arg2:T10	
R18	Experiences Arg1:T82 Arg2:T43	
R17	Experiences Arg1:T53 Arg2:T43	
R19	Has_Duration_or_Interval Arg1:T10 Arg2:T54	
R20	Has_Duration_or_Interval Arg1:T43 Arg2:T54	
R21	Causes Arg1:T55 Arg2:T10	
R22	Causes Arg1:T55 Arg2:T43	
T84	Quantifier_or_Qualifier 421 434	genotipos 1-6
R23	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T84	
R24	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T84	
R25	Experiences Arg1:T53 Arg2:T57	
R26	Experiences Arg1:T82 Arg2:T57	
T85	Quantifier_or_Qualifier 474 486	Genotipo 1-6
R27	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T85	
R28	Has_Age Arg1:T61 Arg2:T63	
R29	Has_Age Arg1:T62 Arg2:T63	
T86	PROC 625 634	seleccion
#69	AnnotatorNotes T86	C0242802; Patient Selection; Research Activity
T87	Quantifier_or_Qualifier 704 709	GT1-6
R30	Causes Arg1:T64 Arg2:T13	
R31	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T87	
T88	PROC 666 675	selección
#70	AnnotatorNotes T88	C0242802; Patient Selection; Research Activity
R32	Overlap Arg1:T88 Arg2:T13	
R33	Overlap Arg1:T63 Arg2:T86	
R34	Experiences Arg1:T65 Arg2:T15	
R35	Experiences Arg1:T56 Arg2:T15	
R36	Location_of Arg1:T44 Arg2:T15	
R37	Causes Arg1:T17 Arg2:T45	
R38	Causes Arg1:T67 Arg2:T17	
R39	Has_Duration_or_Interval Arg1:T17 Arg2:T68	
T89	PROC 850 859	selección
#71	AnnotatorNotes T89	C0242802; Patient Selection; Research Activity
R40	After Arg1:T17 Arg2:T89	
T90	PROC 874 890	recibió un riñon
#72	AnnotatorNotes T90	C0022671; Kidney Transplantation; Therapeutic or Preventive
R41	Location_of Arg1:T14 Arg2:T90	
R42	Experiences Arg1:T69 Arg2:T90	
R43	Experiences Arg1:T65 Arg2:T90	
R44	Experiences Arg1:T56 Arg2:T90	
T91	PROC 947 956	selección
#73	AnnotatorNotes T91	C0242802; Patient Selection; Research Activity
R45	Before Arg1:T90 Arg2:T91	
R46	Overlap Arg1:T90 Arg2:T71	
R47	Overlap Arg1:T46 Arg2:T71	
R48	Negation Arg1:T58 Arg2:T47	
R49	Experiences Arg1:T72 Arg2:T47	
R50	Experiences Arg1:T73 Arg2:T48	
R51	Overlap Arg1:T48 Arg2:T74	
T92	Quantifier_or_Qualifier 1082 1089	estable
#74	AnnotatorNotes T92	C0205360; Stable status; Qualitative Concept
R52	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T92	
R53	Used_for Arg1:T18 Arg2:T48	
R54	Used_for Arg1:T19 Arg2:T48	
R55	Used_for Arg1:T20 Arg2:T48	
R56	Used_for Arg1:T21 Arg2:T48	
R57	Used_for Arg1:T22 Arg2:T48	
R58	Used_for Arg1:T23 Arg2:T48	
R59	Overlap Arg1:T23 Arg2:T74	
R60	Overlap Arg1:T18 Arg2:T74	
R61	Overlap Arg1:T19 Arg2:T74	
R62	Overlap Arg1:T20 Arg2:T74	
R63	Overlap Arg1:T21 Arg2:T74	
R64	Overlap Arg1:T22 Arg2:T74	
R65	Experiences Arg1:T75 Arg2:T60	
T93	Observation 1253 1296	se considera que van a quedarse embarazadas
#75	AnnotatorNotes T93	C0032992; Pregnancy, Planned; Finding
R66	After Arg1:T83 Arg2:T77	
R67	After Arg1:T83 Arg2:T78	
T94	PROC 1308 1315	estudio
#76	AnnotatorNotes T94	C0008976; Clinical Trials; Research Activity
R68	Overlap Arg1:T60 Arg2:T94	
R69	Overlap Arg1:T76 Arg2:T94	
R70	Overlap Arg1:T93 Arg2:T94	
R71	Overlap Arg1:T83 Arg2:T94	
R72	Has_Dose_or_Strength Arg1:T24 Arg2:T78	
T95	Quantifier_or_Qualifier 1438 1448	fibrosante
R73	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T95	
A7	Status T95 History_of
R74	Location_of Arg1:T49 Arg2:T27	
R75	Location_of Arg1:T26 Arg2:T27	
#77	AnnotatorNotes T27	C4087495; Renal retransplantation; Therapeutic or Preventive Procedure | C4087552; Liver retransplantation; Therapeutic or Preventive Procedure
#78	AnnotatorNotes T37	C0815080; organ rejection; Pathologic Function
#79	AnnotatorNotes T32	C0815080; organ rejection; Pathologic Function
R76	Used_for Arg1:T33 Arg2:T35	
R79	Location_of Arg1:T29 Arg2:T37	
R80	Location_of Arg1:T30 Arg2:T37	
R81	Location_of Arg1:T29 Arg2:T31	
R82	Location_of Arg1:T30 Arg2:T31	
R77	Has_Dose_or_Strength Arg1:T33 Arg2:T79	
R83	Has_Duration_or_Interval Arg1:T33 Arg2:T80	
T96	PROC 1643 1652	seleccion
#80	AnnotatorNotes T96	C0242802; Patient Selection; Research Activity
R84	Overlap Arg1:T35 Arg2:T96	
#81	AnnotatorNotes R84	(?)
T97	Observation 1496 1519	resistente a esteroides
R85	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T97	
R86	Overlap Arg1:T34 Arg2:T81	
R87	Before Arg1:T16 Arg2:T34	
R88	Location_of Arg1:T36 Arg2:T34	
#82	AnnotatorNotes T36	C1183745; Vasculature of liver; Body Part, Organ, or Organ Component
T98	ANAT 1720 1731;1743 1748	vasculatura renal
R89	Location_of Arg1:T98 Arg2:T34	
R90	After Arg1:T41 Arg2:T8	
R91	After Arg1:T7 Arg2:T8	
R92	Location_of Arg1:T29 Arg2:T32	
R93	Location_of Arg1:T30 Arg2:T32	
R94	Experiences Arg1:T66 Arg2:T17	
R95	Before Arg1:T93 Arg2:T83	
#83	AnnotatorNotes R72	(?)
#84	AnnotatorNotes T78	C1762893; Date last dose; Temporal Concept
#85	AnnotatorNotes T34	C0432485; Complication of transplant; Pathologic Function
A8	Experiencer T53 Patient
A9	Experiencer T82 Patient
A10	Experiencer T62 Patient
A11	Experiencer T61 Patient
A12	Experiencer T56 Patient
A13	Experiencer T65 Patient
A14	Experiencer T66 Other
A15	Experiencer T69 Patient
A16	Experiencer T70 Other
A17	Experiencer T72 Patient
A18	Experiencer T73 Patient
A19	Experiencer T75 Patient
A20	Status T83 Future
